Short interest in Design Therapeutics Inc (NASDAQ:DSGN) decreased during the last reporting period, falling from 2.71M to 2.70M. This put 10.56% of the company's publicly available shares short.

Short interest for Design Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Design Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 204.76K shares traded per day, it would take 13.18 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.